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PURPOSE. To identify the factors associated with retinal vessel diameters in the population of
the Thessaloniki Eye Study.
METHODS. Cross-sectional population-based study (age ‡ 60 years). Subjects with glaucoma,
late age-related macular degeneration, and diabetic retinopathy were excluded from the
analyses. Retinal vessel diameters were measured using the IVAN software, and measurements
were summarized to central retinal artery equivalent (CRAE), central retinal vein equivalent
(CRVE), and arteriole to venule ratio (AVR).
RESULTS. The analysis included 1614 subjects. The hypertensive group showed lower values of
CRAE (P ¼ 0.033) and AVR (P ¼ 0.0351) compared to the normal blood pressure (BP) group.
On the contrary, the group having normal BP under antihypertensive treatment did not have
different values compared to the normal BP group. Diastolic BP (per mm Hg) was negatively
associated with CRAE (P < 0.0001) and AVR (P < 0.0001), while systolic BP (per mm Hg) was
positively associated with CRAE (P ¼ 0.001) and AVR (P ¼ 0.0096). Other factors significantly
associated included age, sex, alcohol, smoking, cardiovascular disease history, ophthalmic
medication, weight, and IOP; differences were observed in a stratified analysis based on BP
medication use.
CONCLUSIONS. Our study confirms previous reports about the association of age and BP with
vessel diameters. The negative correlation between BP and CRAE seems to be guided by the
effect of diastolic BP as higher systolic BP is independently associated with higher values of
CRAE. The association of BP status with retinal vessel diameters is determined by diastolic BP
status in our population. Multiple other factors are also independently associated with retinal
vessel diameters.
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The retinal vessels can be noninvasively visualized usingmodern fundus photography equipment, and retinal image
analysis software have enabled the objective and accurate
measurement of retinal vessel diameters.1 The retinal vascula-
ture is considered a unique window to assess vascular health
and to detect early structural changes and pathological features
of the human microcirculation.1,2 Several systemic, environ-
mental, and genetic factors have been shown to influence
retinal vascular calibers, and results from population-based
studies suggest that a wide range of subclinical and clinical
cardiovascular diseases are associated with retinal vascular
calibers.1,2 Moreover, there are reports in the literature about
associations between ophthalmic diseases (glaucoma, age-
related macular degeneration, diabetic retinopathy) and retinal
vessel diameters.1 However, retinal vessel diameter measure-
ments have not been introduced so far in the clinical setting of
managing cardiovascular or ophthalmic patients.1 Nevertheless,
the idea of introducing retinal vessel diameter measurements as
a biomarker for cardiovascular patients may be promising.
Moreover, association of retinal vascular caliber with the
diagnosis or prognosis of ophthalmic diseases could provide
insight for the pathogenetic mechanisms underlying the
respective diseases.
The development of normative databases based on large
population-based cohorts conducted in different populations is
critical for the investigation of retinal vessel diameters in
clinical settings.3 However, due to the numerous systemic and
environmental factors affecting retinal vessel diameters, nor-
mative databases have not been developed so far. Retinal vessel
diameters have been analyzed in previous population-based
studies and associations with several factors have been
identified. Specifically, narrower retinal arterial diameters and
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smaller arteriovenous ratio have been associated with older
age, higher blood pressure, and obesity. On the contrary, wider
retinal venular diameters have been associated with younger
age, impaired fasting glucose and diabetes, dyslipidemia,
obesity, systemic markers of inflammation, endothelial dys-
function, and cigarette smoking. Genetic factors and ophthal-
mic diseases have been also associated with retinal vessel
diameters.2 However, it may be difficult to determine normal
values across different individuals or populations and account
for the confounding effect of systemic and ocular diseases.2 In
addition, the confounding factors and their effect on retinal
vessel diameters may differ among different populations.2
The Thessaloniki Eye Study (TES) is a population-based
study of the major eye diseases conducted in the Greek
population. It is one of the few large population-based studies
conducted in European populations and one of the few
population-based studies conducted in a Mediterranean pop-
ulation. It is also the only population-based study where retinal
vessel diameters were analyzed in a south-European, Mediter-
ranean population. Apart from the detailed ophthalmic
examination protocol, detailed history (including systemic
and ophthalmic diseases, demographic factors, and lifestyle)
was recorded for all the TES participants. Fundus photos were
also obtained from TES participants. Therefore, the TES offers a
unique opportunity to assess the distribution of retinal vessel
diameters in an elderly south European–Mediterranean popu-
lation and identify associations with ocular and systemic
factors and disease biomarkers.
METHODS
The Thessaloniki Eye Study is a cross-sectional population-
based study of chronic eye diseases in the population of
Thessaloniki, which is the major urban center in Northern
Greece. The study was approved by the Aristotle University
Ethics Committee and the Institutional Review Board of the
University of California, Los Angeles. All study procedures
adhered to the principles outlined in the Declaration of
Helsinki for research involving human subjects and all
participants gave written informed consent before their
participation.
Details about the recruitment process have been described
previously.4 Briefly, the initial recruitment frame of the
Thessaloniki Eye Study consisted of 5000 people 60 years of
age or older who were selected randomly in February 1999
from approximately 321,000 persons registered in the munic-
ipality registers of the city of Thessaloniki. Randomization was
provided by the municipality statistical service. Subjects from
the Thessaloniki Eye Study recruitment group were contacted
by phone or mail to ascertain their willingness to participate in
the study. Subjects who agreed to participate were invited to
the Thessaloniki Eye Study center at the Aristotle University of
Thessaloniki for an extensive ophthalmic screening examina-
tion. A home visit eye examination was arranged for persons
unable to visit the study examination center because of illness
or major disability. Among the 3617 eligible subjects, 2554
participated in the study (participation rate, 71%); of these,
2261 (89%) had the clinic visit examination and 293 (11%) had
the home visit examination.4 Only clinic-visit participants, who
had fundus photography, were included in the present
analyses.
All clinic visit participants were interviewed for demo-
graphic data (age, sex), ophthalmic and systemic diseases
(hypertension, diabetes, cardiovascular disease, history of
heart attack, coronary artery bypass or vascular surgery, and
migraines), systemic medications (use of antihypertensive and
diabetes treatment), and lifestyle (smoking, alcohol consump-
tion, diet, and hours of sleep per day). In order to minimize any
recall bias related to the use of systemic medications, subjects
had been specifically instructed during phone contact to bring
all medications that they were receiving to the examination
center. Ophthalmic examination included visual acuity mea-
surement, Humphrey automated perimetry (Carl Zeiss Medi-
tec, Dublin, CA, USA), slit-lamp examination, applanation
tonometry, gonioscopy, and dilated fundus examination.
Details of observation procedures are described elsewhere.4
In addition, dilation was conducted in all study participants;
those with an occludable angle underwent laser peripheral
iridotomy and were examined subsequently under pupil
dilation. Blood pressure (BP) was considered as the average
of two readings taken with an automated sphygmomanometer
(OMRON 705 CP; OMRON Corporation, Kyoto, Japan) at least
5 minutes apart in the same arm, with the cuff approximately
level with the heart. Readings were obtained before instillation
of mydriatic drops and after the participant was seated for 10
minutes. Also, weight and height were measured.
Retinal Vessel Diameter Measurements
Fundus photography was performed for all clinic visit
participants after pupil dilation with tropicamide 1% and
phenylephrine hydrochloride 2.5%. Two stereo-pairs of fundus
photos centered on the optic disc (for fields of 208 and 358)
and one stereo-pair of fundus photo centered on the macula
(for field of 508) were performed. For the purpose of this study
the pair of optic disc centered photos was used (field of 358).
Retinal vessel diameters for all vessels coursing through a
specified zone 0.5 to 1 disc diameter away from the optic disc
margin (Figure) were measured from high-resolution digitized
fundus photos of TES participants using a semi-automated
system (IVAN software, University of Wisconsin at Madison),
and the central retinal artery equivalent (CRAE) and central
retinal vein equivalent (CRVE) were calculated based on the six
largest arterioles and venules, as previously described in the
literature (using the Hubbard et al formulas as revised by
Knudtson et al.).5,6 The process proposed by the software
developers for the use of the software (including scale factor
calculation and configuration file creation) were followed. The
automated components of the software used include place-
FIGURE. Interface of IVAN software measurement.
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ment of the overlying grid centered on the optic disc, vessel
type identification and width measurements for vessels. The
manual components include the option to override any of the
initial automated decisions or measurements. This would
include adjusting the placement of the grid, changing the
vessel type, deleting vessels, re-measuring vessels, and adding
significant vessels missed in the initial calculation. The arteriole
to venule ratio (AVR) was also calculated. A trained grader,
masked to participant characteristics, completed the retinal
vessel diameter measurements in all TES participants. These
measurements have been shown to be highly reproducible in
previous studies.5 Following the training of the grader, a small
reproducibility study was conducted to confirm the consisten-
cy of the measurements. This showed excellent values of
intraclass correlation coefficient (>0.85) for all measured
parameters (CRAE, CRVE, AVR). One fundus camera (Topcon
Corp, Japan) was used for the purposes of the present study.
Details about glaucoma and pseudoexfoliation (PEX)
definitions were described previously.4,7 Late age-related
macula degeneration (AMD) was defined by the presence of
either geographic atrophy (GA) or neovascular-exudative
maculopathy (NV), as proposed by the International ARM
Epidemiological Study Group.8
Diabetic retinopathy was defined by the presence of typical
retinopathy lesions of any stage (microaneurysms, hemorrhag-
es, venous beading, intraretinal microvascular abnormalities,
neovascularization of the disc or retina) as described by the
Early Treatment Diabetic Retinopathy Study.9
In TES three independent ophthalmologist graders were
responsible for the assessment of the patients. A consensus
agreement between at least two of them was required to assign
any diagnosis. When disagreement between the graders
existed, an open discussion for final classification and diagnosis
was carried out. The principal investigator (F.T.) examined all
study participants and was responsible for the final adjudica-
tion of diagnosis.
For the present study, all subjects with glaucoma, late AMD,
or any stage of diabetic retinopathy in either eye were
excluded from the analysis. Exclusion criteria also included
subjects without fundus photo in at least one eye, subjects
with no gradable fundus photo in at least one eye because of
media opacities (cornea scarring, dense cataract, vitreous
hemorrhage, etc.), and subjects in whom vessel diameters
could not be measured in at least six arteries and veins in at
least one eye.
Statistical Analyses
The CRAE, CRVE, and AVR were the dependent variables
included in the analyses. Association of retinal vessel diameters
(CRAE, CRVE, AVR) with demographic and lifestyle factors, BP,
medical and ophthalmic history, intraocular pressure (IOP),
and other ophthalmic variables was assessed in univariate
analyses first. The continuous variables included in the analysis
were height, weight, body mass index (BMI), sleep hours,
systolic blood pressure (SBP), diastolic blood pressure (DBP),
IOP, and mean perfusion pressure (MPP). The categorical
variables included in the analysis were age (age groups: 60–69,
70–79, ‡80), sex, sleep in the afternoon, frequency of
vegetable consumption, alcohol intake, smoking, history of
hypertension, history of diabetes mellitus, history of cardio-
vascular disease, history of migraines, history of heart attack,
history of coronary surgery, use of hypertension medication,
use of diabetes medication (tablets), use of insulin, current
systemic steroid use, past systemic steroid use, BP status, SBP
status, DBP status, use of ophthalmic medication, iris
pseudoexfoliation, lens pseudoexfoliation, any pseudoexfolia-
tion (iris or lens), lens status (phakic, pseudophakic or
aphakic), hormone replacement therapy (only in females).
Vegetable consumption data were grouped in the following
groups: less than once a week, one to three times a week, at
least once a day. Based on the answers provided by the
participants, regular alcohol intake was defined as consump-
tion of any type of alcohol greater or equal to once a month.
Occasional alcohol intake was defined as consumption of any
type of alcohol less than once a month. A subject was classified
as a nonsmoker if he/she had smoked fewer than 100
cigarettes in his/her lifetime, as a former smoker if he/she
had smoked more than this number of cigarettes in his/her
lifetime but had stopped smoking at least 1 year prior to the
examination, and as current smoker if he/she had not stopped
smoking or stopped smoking less than 1 year prior to the
examination.
BP, DBP, and SBP status were defined as following: DBP
values lower than 90 mm Hg and SBP values lower than 140
mm Hg were considered normal. In evaluation of SBP, subjects
were classified as having SBP within normal limits (SBP-WNL
group), normal SBP as a result of antihypertensive treatment
(SBP-WNL-Tx group), or high SBP regardless of treatment (SBP-
Htn group). In evaluation of DBP, subjects were classified as
having DBP within normal limits (DBP-WNL group), normal
DBP as a result of antihypertensive treatment (DBP-WNL-Tx
group), or high DBP regardless of treatment (DBP-Htn group).
Similarly, subjects were classified in three groups by BP status
(both SBP and DBP): BP (both SBP and DBP) within normal
limits (BP-WNL group), normal BP (both SBP and DBP) as a
result of antihypertensive treatment (BP-WNL-Tx group), high
BP (SBP or DBP) regardless of treatment (BP-Htn group). Mean
perfusion pressure (MPP) was also calculated as (2/3) X [DBPþ
(SBP -DBP)/3] – IOP and included in the analysis.
Pearson correlation coefficient was used to assess the
association of quantitative variables with retinal vessel
diameters (CRAE, CRVE, AVR), while univariate linear regres-
sion was used to assess the association of categorical variables
with retinal vessel diameters. P values were considered
statistically significant when less than 0.05. All variables with
P value lower than 0.2 in the univariate models for any
dependent variable (CRAE, CRVE, AVR) were included in the
multivariable linear regression model.
RESULTS
From the 2261 clinic visit participants, subjects with glaucoma,
late AMD, or any stage of diabetic retinopathy in either eye
were excluded from the analysis, leaving data from 1772
subjects available for consideration of analysis. Subjects
without fundus photos or subjects with no gradable fundus
photo in either eye because of media opacities (cornea
scarring, dense cataract, vitreous hemorrhage, etc.) were
excluded from the analysis as were subjects in whom vessel
diameters could not be measured in at least six arteries and
veins in at least one eye. Thus a total of 1641 TES participants
were included in the univariate analysis. The mean CRAE in our
population was 148.61 lm (SD 6 14.29 lm), the mean CRVE
was 227.44 lm (621.16 lm), and the mean AVR was 0.66
(60.06); 1614 subjects were included in the multivariable
linear regression analysis as 27 participants had missing data in
at least one of the variables included in the multivariable
model.
The descriptive statistics for categorical and continuous
variables included in the analyses are summarized in Tables 1
and 2, respectively. Table 3 summarizes the Pearson correlation
coefficient between retinal vessel diameters and the continu-
ous variables included in the analysis, and Table 4 summarizes
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the univariate linear regression results (P values) for CRAE,
CRVE, and AVR. The multivariable linear regression results for
CRAE, CRVE, and AVR are summarized in Tables 5, 6, and 7,
respectively.
The results presented in Table 5 show that SBP, DBP, age,
alcohol, smoking, BP status, history of cardiovascular disease,
and ophthalmic medications are statistically significantly
associated with CRAE in the multivariable linear regression
analysis. More specifically, higher SBP (per mm Hg) was
associated with increased values of CRAE (slope estimate – SE
¼ 0.083 lm, P¼ 0.0011), while higher DBP (per mm Hg) was
associated with decreased values (SE ¼ 0.248 lm, P <
0.0001). Age 80 years or older was associated with decreased
values of CRAE (SE ¼3.884 lm, P¼ 0.025) compared to the
reference group aged 60 to 69 years. Regular alcohol intake (SE
¼2.109 lm, P¼ 0.017) was associated with decreased values
of CRAE compared to no alcohol intake while current smoking
was associated with increased values of CRAE (SE¼ 2.583 lm,
P ¼ 0.0068) compared to the nonsmoking group. High BP
regardless of antihypertensive treatment was associated with
decreased values of CRAE (SE ¼ 3.396 lm, P ¼ 0.0033)
compared to normal BP without treatment. On the contrary,
the group having SBP < 140 mm Hg and DBP < 90 mm Hg
under antihypertensive treatment did not have different values
of CRAE compared to the normal BP group (P ¼ 0.2056).
History of cardiovascular disease was associated with increased
values of CRAE (SE¼2.371 lm, P¼0.0048). Use of ophthalmic
medications was associated with increased values of CRAE (SE
¼ 3.551 lm, P ¼ 0.0217).
The results presented in Table 6 show that the factors
statistically significantly associated with CRVE were DBP, age,
sex, and smoking. Higher DBP (per mm Hg) was associated
with decreased values of CRVE (SE¼0.143 lm, P¼ 0.0142).
Age 80 years or older was associated with decreased values of
CRVE (SE¼8.093 lm, P¼ 0.002) compared to the reference
TABLE 1. Descriptive Statistics for Categorical Variables (Glaucoma,
AMD, and Diabetic Retinopathy Subjects Were Excluded)
Variable Category Frequency
Percentage
%
Age, N ¼ 1641 60–69 913 55.64
70–79 644 39.24
‡80 84 5.12
Sex, N ¼ 1641 Male 902 54.97
Female 739 45.03
Sleep in the afternoon,
N ¼ 1641
No 455 27.73
Yes 1186 72.27
Vegetable consumption,
N ¼ 1641
<1 a week 102 6.22
1–3 a week 907 55.27
‡1 a day 632 38.51
Regular alcohol intake,
N ¼ 1641
No 362 22.06
Yes 1279 77.94
Smoking status,
N ¼ 1641
Never 770 46.92
Current smoker 347 21.15
Ex-smoker 524 31.93
Hormone replacement,
N ¼ 737*
No 596 80.87
Yes 141 19.13
Missing 904
Hypertension history,
N ¼ 1637
No 779 47.59
Yes 858 52.41
Unknown 4
Diabetes history,
N ¼ 1639
No 1453 88.65
Yes 186 11.35
Unknown 2
Cardiovascular history,
N ¼ 1634
No 1087 66.52
Yes 547 33.48
Unknown 7
Migraine history,
N ¼ 1641
No 1565 95.37
Yes 76 4.63
Heart attack history,
N ¼ 1639
No 1495 91.21
Yes 144 8.79
Unknown 2
Coronary surgery
history, N ¼ 1641
No 1483 90.37
Yes 158 9.63
Hypertension
medication, N ¼ 1641
No 798 48.63
Yes 843 51.37
Diabetes medication,
N ¼ 1640
No 1516 92.44
Yes 124 7.56
Unknown 1
Insulin, N ¼ 1641 No 1628 99.21
Yes 13 0.79
Steroid use at present,
N ¼ 1638
No 1579 96.4
Yes 59 3.6
Unknown 3
Steroid use in the past,
N ¼ 1633
No 1550 94.92
Yes 83 5.08
Unknown 8
HTN_BP_Meds,
N ¼ 1641
Normal 363 22.12
Normal with Tx 255 15.54
High 1023 62.34
HTN_SBP_Meds,
N ¼ 1641
Normal 408 24.86
Normal with Tx 292 17.79
High 941 57.34
HTN_DBP_Meds
N¼1641
Normal 522 31.81
Normal with Tx 506 30.83
High 613 37.36
Ophthalmic medication,
N ¼ 1641
No 1553 94.64
Yes 88 5.36
Iris PXE, N ¼ 1641 No 1554 94.7
Yes 87 5.3
Lens PXE, N ¼ 1641 No 1566 95.43
Yes 75 4.57
TABLE 1. Continued
Variable Category Frequency
Percentage
%
Any PXE, N ¼ 1641 No 1528 93.11
Yes 113 6.89
Lens status, N ¼ 1641 Phakic 1499 91.35
Pseudophakic 139 8.47
Aphakic 3 0.18
Tx, treatment; PXE, pseudoexfoliation.
* Hormone replacement therapy applied only to females. The high
number of missing has to do with the number of males who were not
receiving the treatment.
TABLE 2. Descriptive Statistics for Continuous Variables (Glaucoma,
AMD, and Diabetic Retinopathy Subjects Were Excluded)
Variable N Mean SD Minimum Maximum
Height, cm 1634 164.2 9.1 139 190
Weight, kg 1635 76.5 12.2 40 130
BMI, kg/m2 1634 28.4 4.2 16 52.7
Sleep hours 1641 7.5 1.6 1 14
SB, mm Hg 1641 144.3 22.0 81.5 249
DBP, mm Hg 1641 85.2 12.6 47.5 138
IOP, mm Hg 1637 14.9 3.1 7.7 29
MPP, mm Hg 1637 55.0 9.6 25.4 104.4
CRAE, lm 1641 148.61 14.29 80.65 191.79
CRVE, lm 1641 227.44 21.16 150.49 340.73
AVR, lm 1641 0.66 0.056 0.49 0.86
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TABLE 3. Pearson Correlation Coefficient for Retinal Vessel Diameters and Continuous Variables. Prob > jrj under H0: Rh¼ 0
Height Weight BMI
Sleep
Hours SBP DBP IOP MPP
CRAE
Correlation coefficient 0.08677 0.08367 0.02086 0.01983 0.1005 0.19829 0.00489 0.16536
P value 0.0004 0.0007 0.3993 0.4221 <.0001 <.0001 0.8434 <.0001
N 1634 1635 1634 1641 1641 1641 1637 1637
CRVE
Correlation coefficient 0.03586 0.03084 0.00677 0.01277 0.05465 0.06834 0.03847 0.0519
P value 0.1474 0.2126 0.7845 0.6052 0.0268 0.0056 0.1197 0.0356
N 1634 1635 1634 1641 1641 1641 1637 1637
AVR
Correlation coefficient 0.1426 0.12606 0.02452 0.00809 0.05466 0.14757 0.04395 0.12772
P value <.0001 <.0001 0.322 0.7432 0.0268 <.0001 0.0755 <.0001
N 1634 1635 1634 1641 1641 1641 1637 1637
TABLE 4. Univariate Linear Regression Results (P Values) for CRAE, CRVE, and AVR
Variable Categories
P Value
(CRAE)
Slope Estimate
CRAE
P Value
(CRVE)
Slope Estimate
CRVE
P Value
(AVR)
Slope Estimate
AVR
Age 60–69 0.3541 1.5108178 0.001 7.9237906 0.0151 0.015442993
70–79 0.2666 1.842707 0.0012 7.9323085 0.0312 0.0139197723
‡80 Reference
Sex Male vs. female <0.0001 2.8316693 0.0196 2.4492804 <0.0001 0.019496572
Sleep in the afternoon No vs. yes 0.0433 1.592212 0.4148 0.9520492 0.2033 0.003910878
Vegetable consumption <1 a week 0.4555 1.1375487 0.5561 1.3300773 0.1419 0.008730951
1–3 a week 0.0926 1.2452424 0.5041 0.7330346 0.2214 0.0035286101
‡1 a day Reference
Regular alcohol intake No vs. yes 0.0007 2.86465 0.9094 0.1433614 0.0003 0.012002143
Smoking status Never 0.0125 2.0155399 0.3951 1.0089008 <0.0001 0.012244255
Current smoker 0.0003 3.5499084 <0.0001 7.000314 0.3027 0.003946774
Ex-smoker Reference
Hormone replacement No vs. yes 0.6751 0.5708596 0.0567 3.739095 0.0851 0.008933957
Hypertension history No vs. yes 0.3931 0.6047046 0.838 0.2144346 0.4941 0.001888669
Diabetes history No vs. yes 0.8098 0.2681472 0.4429 1.2657408 0.5505 0.00259344
Cardiovascular history No vs. yes 0.0035 2.1903112 0.3806 0.9736688 0.0167 0.006991051
Migraine history No vs. yes 0.2026 2.1393876 0.2964 2.5965328 0.6058 0.003379132
Heart attack history No vs. yes 0.6412 0.5816631 0.1125 2.932429 0.3046 0.004995768
Coronary surgery history No vs. yes 0.5363 0.7399402 0.093 2.9748455 0.3092 0.004744138
Hypertension medication No vs. yes 0.5296 0.4439265 0.8217 0.2356052 0.3588 0.002526365
Diabetes medication No vs. yes 0.9973 0.0044534 0.8846 0.2869953 0.8372 0.001070368
Insulin No vs. yes 0.5046 2.656288 0.9609 0.2892894 0.5557 0.0091473256
Steroid use at present No vs. yes 0.7052 0.7173188 0.2756 3.0617161 0.3794 0.006501755
Steroid use in the past No vs. yes 0.6156 0.8084587 0.4187 1.9320123 0.7444 0.002047478
HTN_BP_Meds Normal <0.0001 4.490247 0.0112 3.2743864 0.0019 0.010546166
Normal with Tx 0.0002 3.7479942 0.0432 2.9912203 0.0303 0.008432051
High Reference
HTN_SBP_Meds Normal <0.0001 3.9180762 0.0329 2.6750792 0.0028 0.009867246
Normal with Tx 0.0009 3.1576572 0.0993 2.3349173 0.0366 0.007788345
High Reference
HTN_DBP_Meds Normal <0.0001 5.6524266 0.0213 2.9007597 <0.0001 0.016840871
Normal with Tx <0.0001 5.25648 0.0157 3.0694676 <0.0001 0.014710073
High Reference
Ophthalmic medication No vs. yes 0.009 4.0884329 0.0718 4.1752522 0.338 0.005852887
Iris PXE No vs. yes 0.3733 1.4022074 0.9057 0.276382 0.2958 0.006421182
Lens PXE No vs. yes 0.922 0.165563 0.9484 0.161905 0.7528 0.002075377
Any PXE No vs. yes 0.2289 1.676869 0.4477 1.5671016 0.5063 0.003612276
Lens status Phakic vs. pseudophakic/
aphakic
0.3882 1.0831882 0.0607 3.4850851 0.2404 0.00574537
The slope estimate for continuous variables represents the amount change in the outcome variable with every one unit change in the predictor
variable, while the estimate for categorical variables represents the amount change in the outcome variable between the corresponding group and
the reference group.
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group age 60 to 69 years. Female sex was associated with
decreased values of CRVE (SE ¼ 3.221 lm, P ¼ 0.0477)
compared to male sex. Current smoking was associated with
increased values of CRVE (SE ¼ 6.962 lm, P < 0.0001)
compared to the nonsmoking group.
The results presented in Table 7 show that the factors
significantly affecting AVR were weight, SBP, DBP, IOP, sex,
vegetable consumption, smoking, BP status, and cardiovascular
disease history. Higher weight (per kg) was associated with
decreased AVR (SE¼0.000259, P¼ 0.0482). Higher SBP (per
mm Hg) was associated with increased AVR (SE¼ 0.000259, P
¼ 0.009), while higher DBP (per mm Hg) was associated with
decreased AVR (SE¼0.000655, P < 0.0001). Higher IOP (per
mm Hg) was also associated with increased values of AVR (SE¼
0.000912, P ¼ 0.041). Female sex was associated with
increased AVR (SE¼ 0.013305, P¼ 0.0017) compared to male
sex. Consuming vegetables less than once a week was
associated with decreased AVR (SE ¼0.012710, P ¼ 0.033)
compared to vegetable consumption more than once a day.
Current smoking was associated with decreased AVR (SE ¼
0.0087, P ¼ 0.02) compared to nonsmoking. High BP
regardless of antihypertensive treatment was associated with
decreased AVR (SE¼0.009557, P¼ 0.0351) compared to the
normal BP. On the contrary, the group having SBP < 140 mm
Hg and DBP < 90 mm Hg under antihypertensive treatment did
not have different values of AVR compared to the normal BP
group (P¼0.2587). Individuals with a history of cardiovascular
disease had increased AVR (SE ¼ 0.009218, P ¼ 0.0052)
compared to those with no history of cardiovascular disease.
The results presented in Table 8 compare the factors
affecting retinal vessel diameters in the participants receiving
BP medication and the participants not receiving BP medica-
tion. In this stratified analysis, differences between the two
groups were observed. Factors significantly associated with
CRAE in individuals not receiving BP medication were DBP
(per mm Hg, SE ¼ 0.2903, P < 0.0001), history of
cardiovascular disease compared to no history (SE ¼ 2.9451,
P¼ 0.02), ophthalmic medication use compared to no use (SE
¼ 4.9202, P¼ 0.03), and lens status (SE¼5.3964, P¼ 0.006)
for the pseudophakic/aphakic group compared to the refer-
ence phakic group. Factors significantly associated with CRAE
in individuals receiving BP medication were DBP (per mm Hg,
SE¼0.2688, P < 0.0001), age (SE¼2.3041, P¼ 0.03 for the
7079 group/ SE ¼ 4.9693, P ¼ 0.02 for the ‡80 group)
compared to the 60 to 69 reference group, current smoking
(SE ¼ 3.7174, P ¼ 0.008) compared to never smokers and
history of cardiovascular disease compared to no history (SE¼
2.3751, P¼ 0.03). Factors significantly associated with CRVE in
participants not receiving BP medication were DBP (per mm
Hg, SE¼0.3016, P¼ 0.001) and smoking for current smokers
(SE ¼ 7.8440, P ¼ 0.0001) compared to nonsmokers. Factors
significantly associated with CRVE in participants receiving BP
medication were age (SE¼9.213, P¼0.004 for the ‡80 group
compared to the 6069 reference group) and smoking (SE ¼
6.784, P ¼ 0.001) for current smokers compared to nonsmok-
TABLE 5. Multivariable Linear Regression Results for CRAE
Parameter
Slope
Estimate Pr > jtj
Height (per cm) 0.0348151 0.552
Weight (per kg) 0.0166995 0.6182
SBP (per mm Hg) 0.082642 0.0011
DBP (per mm Hg) 0.2476165 <.0001
IOP (per mm Hg) 0.1181001 0.2991
Age
70–79 1.0835655 0.1502
‡80 3.8841049 0.025
60–69 Reference
Sex: female vs. male 1.1265566 0.2958
Sleep in the afternoon: yes vs. no 0.8902254 0.2639
Vegetable consumption
<1 a week 1.6371289 0.2812
1–3 a week 1.2670733 0.0797
‡1 a day Reference
Regular alcohol intake: yes vs. no 2.1087241 0.017
Smoking status
Current smoker 2.5825959 0.0068
Ex-smoker 0.4826856 0.5906
Never Reference
HTN_BP_Meds
BP-WNL-Tx 1.4739587 0.2056
BP-HTN 3.3959876 0.0033
BP-WNL Reference
History of cardiovascular disease: yes vs. no 2.3709471 0.0048
Heart attack history: yes vs. no 0.2744745 0.843
Coronary surgery history: yes vs. no 0.1452581 0.9097
Ophthalmic medication: yes vs. no 3.5507315 0.0217
Lens: pseudophakic/aphakic vs. phakic 2.1023192 0.1031
The slope estimate for continuous variables represents the amount
change in the outcome variable with every one unit change in the
predictor variable, while the estimate for categorical variables
represents the amount change in the outcome variable between the
corresponding group and the reference group.
TABLE 6. Multivariable Linear Regression Results for CRVE
Parameter
Slope
Estimate Pr > jtj
Height (per cm) 0.0955916 0.2793
Weight (per kg) 0.0730754 0.1485
SBP (per mm Hg) 0.0374864 0.325
DBP (per mm Hg) 0.1434083 0.0142
IOP (per mm Hg) 0.1566071 0.3616
Age
70–79 0.5566405 0.6242
Age: ‡80 8.0926895 0.002
Age: 60–69 Reference
Sex: female vs. male 3.2210524 0.0477
Sleep in the afternoon: yes vs. no 1.911443 0.112
Vegetable consumption
<1 a week 1.866383 0.4156
1–3 a week 0.8172173 0.4538
‡1 a day Reference
Regular alcohol intake: yes vs. no 1.1700926 0.3797
Smoking status
Current smoker 6.9618213 <.0001
Ex-smoker 0.1600185 0.9059
Never Reference
HTN_BP_Meds
BP-WNL-Tx 0.3656879 0.8351
BP-HTN 2.1030168 0.2281
BP-WNL Reference
History of cardiovascular disease: yes vs. no 0.3736628 0.7681
Heart attack history: yes vs. no 1.3821273 0.5086
Coronary surgery history: yes vs. no 1.8092627 0.3493
Ophthalmic medication: yes vs. no 4.2225525 0.0704
Lens: pseudophakic/aphakic vs. phakic 2.8365947 0.145
The slope estimate for continuous variables represents the amount
change in the outcome variable with every one unit change in the
predictor variable, while the estimate for categorical variables
represents the amount change in the outcome variable between the
corresponding group and the reference group.
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ers. Factors significantly associated with AVR in the group not
receiving BP medication were weight (per kg, SE¼0.000369,
P¼0.046), sex for females (SE¼0.012072, P¼0.04) compared
to males, vegetable consumption for <1 a week (SE ¼
0.019328, P ¼ 0.02) compared to consumption ‡1 a day,
smoking for current smokers (SE¼0.014323, P¼ 0.004) and
ex-smokers (SE ¼ 0.010978, P ¼ 0.02) compared to
nonsmoking and history of cardiovascular disease compared
to no history of cardiovascular disease (SE ¼ 0.017055, P ¼
0.0008). Factors significantly associated with AVR in the group
receiving BP medication were IOP (per mm Hg SE¼ 0.001290,
P¼0.04), SBP (per mm Hg SE¼0.000329, P¼0.004), DBP (per
mm Hg SE¼0.000987, P < 0.0001), and sex for females (SE¼
0.015412, P ¼ 0.01) compared to males.
DISCUSSION
Retinal vessel diameters have been measured in several
population-based studies conducted in different populations
and their measurements have been associated with ophthalmic
and systemic diseases. However, different populations may
differ in terms of genetic background and environmental
exposures. The TES is the only population-based study
conducted in the Greek population and, therefore, it is a
unique opportunity to identify associations between retinal
vessel diameters and ocular or systemic diseases in this
population. It is also the only population-based study to
analyze retinal vessel diameters in a south European or
Mediterranean population.
Previous population based studies have associated higher
BP values (systolic, diastolic, and mean BP) with decreased
retinal arterial diameters. In these studies, the statistical
approach was to use either mean BP as the only variable
analyzed or to proceed to limited adjustment for some of the
variables that could be affecting retinal vessel diameters (age,
sex, body mass index, smoking history, education level).10–20
In our multivariable model, we considered additional potential
factors as provided by the TES comprehensive data set. We
found that SBP and DBP as continuous variables had an
opposite effect on retinal vessel diameters. In our study, higher
SBP was associated with increased CRAE and AVR values, while
higher DBP was associated with decreased CRAE, CRVE, and
AVR values. The negative association reported in the literature
between BP and retinal arterial diameters seems to be guided
by the effect of DBP. It is obvious from our results that CRAE
and AVR are affected in a higher degree by DBP values than by
SBP. SBP and DBP have been shown in the literature to be
associated with a positive linear relationship.21 The analysis of
our data allows the clarification of the effect of SBP and DBP on
retinal vessel diameter measurements which, to the best of our
knowledge, has not been studied in the literature before. The
different role of SBP and DBP as prognostic factors for
cardiovascular diseases has been analyzed in the literature,
and the significance of SBP over DBP has been shown.22 To our
knowledge, there are no previous studies assessing the
relationship between BP status and retinal vessel diameters.
In our study, the hypertensive group showed lower values of
CRAE and AVR compared to the group having normal BP
without treatment. At the same time, the group having normal
BP as a result of BP lowering treatment did not have
significantly different CRAE and AVR values compared to the
group having normal BP without treatment. This indicates that
the association of BP status with retinal vessel diameters could
be mainly affected by the current DBP level association, as
analyzed before. In addition, the results suggest that the use of
systemic antihypertensive medications effectively reducing BP
within normal limits also preserves the diameters of main
branches in the retinal vasculature.
The association between aging and retinal vessel diameters
has been reported in the literature in several studies. Retinal
arterial and venous diameters decrease 1.4 to 4.8 lm per
decade of aging.10,16,23,24 The negative correlation between
aging and retinal vessel diameters was confirmed in our
population as well. However, it reached statistical significance
only when comparing the groups 60 to 69 years old to those
older than 80.
In our population, females showed decreased values of
CRVE and increased values of AVR. Similar results have been
reported by the Blue Mountains Eye Study,10 the Cardiovascu-
lar Health Study,25 and the Multi-ethnic Study of Atherosclero-
sis (MESA).12 Although estrogens have been proposed as the
factor responsible for this difference observed between males
and females, results in the literature are conflicting about this
suggestion.2
Current smoking was associated with increased values of
CRAE and CRVE and decreased values of AVR in our results.
Similar associations have been reported in the literature.13,15
Interestingly, ex-smokers did not have different values of retinal
vessel diameters compared to nonsmokers in our study. On the
contrary, the Rotterdam study reported increased values of
CRAE and CRVE for ex-smokers compared to nonsmokers.13
Genetic, environmental, or systemic confounders (such as age,
BP, or systemic medication) could explain this difference in the
findings.
TABLE 7. Multivariable Linear Regression Results for AVR
Parameter
Slope
Estimate Pr > jtj
Height (per cm) 3.40007E-05 0.8822
Weight (per kg) 0.00025971 0.0482
SBP (per mm Hg) 0.000258799 0.009
DBP (per mm Hg) 0.000655212 <.0001
IOP (per mm Hg) 0.000911762 0.041
Age
70–79 0.003206388 0.2775
‡80 0.005077717 0.4547
60–69 Reference
Sex: female vs. male 0.013305855 0.0017
Sleep in the afternoon: yes vs. no 0.001828786 0.5583
Vegetable consumption
<1 a week 0.012710084 0.033
1–3 a week 0.003317995 0.2418
‡1 a day Reference
Regular alcohol intake: yes vs. no 0.005568161 0.1077
Smoking status
Current smoker 0.008698857 0.02
Ex-smoker 0.002315531 0.5104
Never Reference
HTN_BP_Meds
BP-WNL-Tx 0.005156696 0.2587
BP-HTN 0.009556977 0.0351
BP-WNL Reference
History of cardiovascular disease: yes vs. no 0.009217592 0.0052
Heart attack history: yes vs. no 0.004327856 0.4257
Coronary surgery history: yes vs. no 0.005321159 0.2894
Ophthalmic medication: yes vs. no 0.003377499 0.5773
Lens: pseudophakic/aphakic vs. phakic 0.000265428 0.9581
The slope estimate for continuous variables represents the amount
change in the outcome variable with every one unit change in the
predictor variable, while the estimate for categorical variables
represents the amount change in the outcome variable between the
corresponding group and the reference group.
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Alcohol consumption was associated with decreased values
of CRAE in our population; however, no association was found
with CRVE and AVR. Similar associations have been reported
previously by the MESA.12 On the contrary, the Rotterdam
Study13 and the Atherosclerosis Risk in Communities Study
(ARIC)26 found association of alcohol consumption with
decreased values of AVR, while the mechanism responsible
for this association has not been clarified. However, in our
study, the association of alcohol consumption with decreased
values of AVR did not reach statistical significance.
A self-reported history of cardiovascular disease was
associated with increased values of CRAE and AVR. There are
several studies in the literature associating retinal vessel
diameters with atherosclerosis markers, inflammation and
dysfunction of vessel endothelium, stroke, coronary heart
disease, and death because of cardiovascular diseases.1,2
However, our results are not directly comparable with the
results of these studies because the accuracy of self-reported
history is different from the accuracy of objective disease
markers used in those studies and because several confounders
(e.g., systemic medication used) could be interfering with this
relationship.
In our study, increased weight was associated with
decreased values of AVR. On the contrary, weight was not
associated with retinal arterial and venous diameters. The
relationship between AVR and weight has been confirmed by
several studies conducted in different populations, along with
an association between weight and retinal arterial and venous
diameters.13,15,19,23,27,28
In our population, the use of ophthalmic medications was
associated with increased values of CRAE. Our analysis did not
include subgroup analysis for different categories of ophthal-
mic medications used by the participants in TES. Investigations
on the Beaver Dam Eye Study reported that the use of topical
beta-blockers as IOP-lowering treatment was associated with
narrowing of the retinal arterial and venous diameters.29
Although glaucoma patients were excluded from the analysis,
there were participants overdiagnosed for glaucoma in our
population.30 This explains that some of those included in the
analysis were receiving ophthalmic medications (including IOP
lowering medications).
Higher IOP was associated with decreased values of AVR in
our population. This finding applies to individuals without
glaucoma since glaucoma subjects were excluded from the
analysis. To our knowledge, there are no previous population-
based studies evaluating the effect of IOP on AVR. Increased IOP
is known to be a risk factor for glaucoma.31 However, it is not
clear from our study whether the effect of IOP on AVR is
involved in the development of glaucomatous optic neuropathy.
Lower vegetable consumption (less than once a week) was
associated with decreased values of AVR compared to the
group consuming vegetables at least once a day. To our
knowledge, there are no previous population-based studies
assessing the effect of diet on retinal vessel diameters.
Decreased AVR has been reported to be associated with
several cardiovascular risk factors.2
The stratified analysis based on BP medication use (or not)
revealed interesting differential findings regarding the factors
affecting retinal vessel diameters. CRAE was associated with
ophthalmic factors (ophthalmic medication and lens status) in
the non-BP treated group only. Conversely, systemic factors
(age and smoking) were associated with CRAE only in the
group receiving BP treatment. DBP was associated with CRVE
in non-BP treatment subjects but not in the BP treatment
group. The opposite applied to subjects over 80 years of age.
Weight, vegetable consumption, smoking and history of
cardiovascular disease were associated with AVR only in the
nontreatment BP group, while the opposite relationships were
found when applied to IOP, SBP, and DBP.
It is not clear from our study if the presence of
hypertension, antihypertensive treatment, or confounding
variable is responsible for the differences observed between
groups. Both the presence of hypertension itself and some
types of treatment could be related with early changes in the
structure and function of the retinal microcirculation.1,2
Moreover age may be a surrogate for the duration of
hypertension or antihypertensive treatment thus potentially
explaining the differences in the findings between those with
and without antihypertensive treatment. DBP presented with
different correlation with CRVE in those receiving or not
receiving antihypertensive treatment (no significant correla-
tion versus negative correlation respectively). Interestingly, we
have previously reported association of DBP with optic disk
structure in the nonglaucoma participants receiving antihy-
pertensive treatment.32 In another analysis, we have found that
diastolic ocular perfusion pressure was significantly associated
with primary open angle glaucoma only in subjects receiving
antihypertensive treatment.33 Considering the complexity of
these issues, carefully designed research and more advanced
mathematical analysis may further elucidate these relationships
and any potential clinical significance.
Our results suggest that various factors are significantly
associated with retinal vessel diameters differently based upon
presence or absence of BP treatment. The factors significantly
associated with retinal vessel diameters include: demographic
data (age and sex), systemic factors (BP, history of cardiovas-
cular disease), ophthalmic factors (IOP and ophthalmic
medication), and lifestyle (current smoking, alcohol consump-
tion, weight, and vegetable consumption). One of the
advantages of our study is that it is a random sample of the
population in a defined geographical area. A limitation of our
study is that the associations found may not be relevant to age
groups younger than 60 years. Another limitation is the fact
that the software used does not allow adjustment for the size of
the optic disc, which could be a source of error since different
disc sizes could affect the measurement of retinal vessel
diameters. The measurement of the retinal vessels is a
standardized distance from the disc, which may create an
artifact in eyes with very large or small disc diameters.
Age and BP have been confirmed as factors statistically
significantly associated with retinal vessel diameters across
different studies and in our population as well. At the same
time, the negative correlation between BP and CRAE reported
in the literature seems to be guided by the effect of DBP as
higher SBP independently is associated with higher values of
CRAE. To our knowledge, our study is the first in the literature
to analyze this association. Multiple other factors (including
demographic, systemic, ophthalmic, and lifestyle factors) are
independently associated with retinal vessel diameters in our
population and BP medication use may affect this association
as well. The associations we found may provide insights on the
role of different factors in retinal vasculature diameters and its
role as a potential biomarker in eye diseases and general health
status. Further research to prospectively identify the impact of
different factors on retinal vessels and analyze the relationship
with ocular and systemic diseases is needed to this direction.
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